← Back
$WGS All transactions

GeneDx Holdings Corp.

▼ SELL

$ Value

$319K

Shares

5,117

Price

$62

Filed

Mar 30

Insider

Name

Stueland Katherine

Title

CHIEF EXECUTIVE OFFICER

CIK

0001689575

Roles

Director Officer

Transaction Details

Transaction Date

2026-03-26

Code

S

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

120,101

Footnotes

Each restricted stock unit ("RSU") represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration. | The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person. | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $60.93 to $61.91 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote and in footnotes 4 through 7 of this Form 4. | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $61.93 to $62.91 per share, inclusive. | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $62.96 to $63.955 per share, inclusive. | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $63.99 to $64.96 per share, inclusive. | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $65.00 to $65.61 per share, inclusive. | Following the reported sale undertaken to satisfy tax withholding liabilities, in addition to the 91,514 shares of Class A Common Stock beneficially owned by the Reporting Person, the Reporting Person held RSUs representing contingent rights to receive up to an aggregate 334,695 shares of the Issuer's Class A Common Stock and options to purchase up to an aggregate 107,610 shares of Class A Common Stock, which RSUs and options vest according to their respective terms. | 25% of the total award vested or vests annually, with the first tranche vested on March 26, 2025, subject to the Reporting Person's continued service to the Issuer on each vesting date. These RSUs do not have an expiration date; they either vest or are cancelled prior to the vesting date.

Filing Info

Accession No.

0001689575-26-000021

Form Type

4

Issuer CIK

0001818331

Stueland Katherine's History

Date Ticker Type Value
2026-03-26 WGS M $0
2026-03-26 WGS $811K
2026-03-26 WGS $319K
2026-03-26 WGS $849K
2026-03-26 WGS $342K
2026-03-26 WGS $645K
2026-03-26 WGS M $0
2026-01-29 WGS M $0
2026-01-29 WGS $155K
2026-01-29 WGS M $0

Other Insiders at WGS (90d)

Insider Bought Sold Last
Stueland Katherine
CHIEF EXECUTIVE OFFICER
$2.8M 2026-03-26
Feeley Kevin
CHIEF FINANCIAL OFFICER
$587K 2026-03-26
Dechairo Bryan
Chief Operating Officer
$851K 2026-02-04